MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 31, 2007; DOI: 10.1124/mol.107.037085


0026-895X/07/7203-502-513$20.00
Mol Pharmacol 72:502-513, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.037085v1
72/3/502    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renner, U.
Right arrow Articles by Ponimaskin, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renner, U.
Right arrow Articles by Ponimaskin, E.

Localization of the Mouse 5-Hydroxytryptamine1A Receptor in Lipid Microdomains Depends on Its Palmitoylation and Is Involved in Receptor-Mediated Signaling

Ute Renner, Konstantin Glebov, Thorsten Lang, Ekaterina Papusheva, Saju Balakrishnan, Bernhard Keller, Diethelm W. Richter, Reinhard Jahn, and Evgeni Ponimaskin

Abteilung Neuro- und Sinnesphysiologie, Physiologisches Institut, Universität Göttingen, Göttingen, Germany (U.R., K.G., E.P., S.B., B.K., D.W.R., E.P.); Center of Molecular Physiology of the Brain, Göttingen, Germany (U.R., D.W.R., E.P.); and Department of Neurobiology, Max-Planck-Institute for Biophysical Chemistry, Göttingen, Germany (T.L., R.J.)

In the present study, we have used wild-type and palmitoylation-deficient mouse 5-hydroxytryptamine1A receptor (5-HT1A) receptors fused to the yellow fluorescent protein- and the cyan fluorescent protein (CFP)-tagged {alpha}i3 subunit of heterotrimeric G-protein to study spatiotemporal distribution of the 5-HT1A-mediated signaling in living cells. We also addressed the question on the molecular mechanisms by which receptor palmitoylation may regulate communication between receptors and Gi-proteins. Our data demonstrate that activation of the 5-HT1A receptor caused a partial release of G{alpha}i protein into the cytoplasm and that this translocation is accompanied by a significant increase of the intracellular Ca2+ concentration. In contrast, acylation-deficient 5-HT1A mutants failed to reproduce both G{alpha}i3-CFP relocation and changes in [Ca2+]i upon agonist stimulation. By using gradient centrifugation and copatching assays, we also demonstrate that a significant fraction of the 5-HT1A receptor resides in membrane rafts, whereas the yield of the palmitoylation-deficient receptor in these membrane microdomains is reduced considerably. Our results suggest that receptor palmitoylation serves as a targeting signal responsible for the retention of the 5-HT1A receptor in membrane rafts. More importantly, the raft localization of the 5-HT1A receptor seems to be involved in receptor-mediated signaling.


Received April 13, 2007; accepted May 31, 2007

Address correspondence to: Dr. Evgeni Ponimaskin. Abteilung Neuro- und Sinnesphysiologie, Physiologisches Institut, Universität Göttingen, Humboldtallee 23, D-37073 Göttingen, Germany. E-mail: eponima{at}gwdg.de







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics